MYC and cancer: Focal amplifications in BRAFmut/MSS cancers were also more common compared to BRAFwt/MSS cancers at 8q (11/33, 33% Vs 1/18, 6%; p = 0.04) predominantly at 8q24.21 covering the Myc locus, and 18q (7/33, 21% Vs 0/18; p = 0.04) affecting 18q11.2 (containing GATA6 and CTAGE).